Members of the ETS gene family are known to be expressed in other members of the ETS gene family may have crucial roles hematopoietic tissues and cell lines, and there is increasing in specific aspects of hematopoietic cell development.
that, in addition to T cell activation, c-ETS-1 may also have a function in normal erythropoiesis.
In this study we have utilized murine retroviral constructs Introduction to express the ETS-1 and ETS-2 genes in the well-established, pluripotent erythroleukemic cell lines K562 and HEL, in order The ETS proteins constitute a highly conserved gene family, to investigate the effects of ETS expression on erythroid differmembers of which are distinguished by high homology within entiation. Our results indicate that increased expression of a DNA binding region referred to as the ETS domain. [1] [2] [3] The ETS-1 has a profound effect on cellular proliferation and the prototypic ETS gene, v-ets, was discovered as part of an expression of erythroid specific markers, while ETS-2 has no oncogenic fusion with viral gag and myb sequences of the detectable effects. These results are consistent with data demtransforming avian retrovirus E26. 4, 5 The E26 virus causes onstrating that ETS-1 gene expression contributes to and is mixed myeloid and erythroid leukemias in birds with a prerequired for hemoglobinization in response to treatment of the dominance of the latter, 6, 7 and when expressed in a murine cells with agents known to induce erythroid differentiation. background, this oncogenic fusion causes a similar in vitro response in mice 8 and regulates the expression of erythroidspecific genes in vitro. 9, 10 Since the discovery of v-ets many Materials and methods other ETS genes have been identified, all but a few of which are transcription factors which interact with DNA at a core Cells and viruses GGA(A/T) sequence. 1, 2, [11] [12] [13] The human homologs of many of these genes including FLI-1, PU.1, ETS-1, ETS-2, ELK-1 and K562, HEL, and CRL9078 (PA317) cells were purchased from ELK-2, have been mapped to chromosomal regions known to the American Type Culture Collection; CRE cells were be involved in translocations characteristic of specific leukeobtained from Dr R Mulligan; K562 and HEL were cultured mias, lymphomas, and other tumors. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] in RPMI medium supplemented with 10% fetal bovine serum Many of the ETS genes are known to be expressed in hema-(FBS) plus antibiotics (Atlanta Biological, Atlanta, GA, USA); topoietic tissues and cell lines. [26] [27] [28] [29] [30] [31] It was demonstrated that CRE and PA317 cells were cultured in Dulbecco's MEM supthe PU.1 gene product is essential for the normal development plemented with antibiotics and 8% calf serum or 10% FBS, of myeloid and B lymphoid lineages, 32 while inactivation of respectively.
ETS-1 leads to increased T cell apoptosis and terminal B cell
Retroviral expression constructs expressing ETS-1 or ETS-2 differentiation. 33 Considering these data it is reasonable that in both the sense and antisense directions were generated in the vector pLRNL 41 as follows: pLE1 (sense) and pLE1AS (reverse orientation): a HindIII-SstII fragment containing the entire coding region of ETS-1 was excised from pSKE1, 42 For each sample, approximately 3 × 10 6 cells were lysed in RIPA buffer containing inhibitors (50 mM Tris-HCl, pH 7.6, Helper-free virus stocks of both sense-and antisenseexpressing viruses were prepared by transfecting ecotropic 100 mM NaCl, 15 mM EDTA, pH 8.0, 1% Triton X-100, 0.5% deoxycholic acid, 10 g/ml aprotinin, 10 g/ml leupeptin and packaging cells (CRE 44 ), harvesting the transiently expressed virus, and infecting the amphotropic packaging cell line 1 mM PMSF). Lysates were sonicated, frozen, and cleared by centrifugation at top speed in a microfuge (20 min at 4°). Pro-PA317. 45 Individual G418-resistant (400 g/ml) colonies of PA317 cells were isolated, expanded, and screened for the tein concentrations were determined using the Bio-Rad assay (BioRad, Hercules, CA, USA), and samples resolved on 8% production of virus on NIH3T3 cells. Stocks prepared from the highest expressors (10 4 -10 5 infectious virus/ml) were used SDS-polyacrylamide gels. Proteins were then transferred to nitrocellulose filters and the presence of ETS-1 was detected to infect human cells.
using antibodies specific for ETS-1 48 in combination with ECL in accordance with specifications of the manufacturer. Expression of the c-raf protein was measured as an internal Induction of differentiation control for protein concentration using the c-raf-specific C12 antibody obtained from Santa Cruz Biotechnology (Santa K562 and HEL cells were induced toward a more erythroid Cruz, CA, USA). phenotype by treatment with either cytosine arabinofuranoside (Ara-C) (0.1 M) or hemin (40 M) (Sigma Chemical, St Louis, MO, USA), for 1-5 days. Differentiation was assessed Analysis of markers of erythroid and megakaryocytic by benzidine staining for hemoglobin and surface marker differentiation analysis.
Hemoglobinization of cells was scored using a modified benzidine staining as previously described. 49 46 For Northern blot hybridization, 20 g of RNA was denatured and subjected to electrophoresis in 1% 7% in the controls, 55% of the hemin-treated and 20% Ara-Ctreated K562 stained positive for hemoglobin ( Figure 1a) . No formaldehyde/agarose gels using 6% formaldehyde as a denaturing agent. RNA was blotted overnight and immobilized on benzidine staining was observed in cultures of untreated HEL cells, whereas 35% of the cells stained positive in response to nitrocellulose filters as previously described. 47 Nitrocellulose filters were then hydridized to specific ␣-32 P dCTP-labto hemin and 7% stained positive in response to Ara-C ( Figure 1b ). Both K562 and HEL cells were more sensitive to eled DNA probes prepared using a random priming kit (Boehringer Mannheim, Indianapolis, IN, USA). Prehybridizinduction by hemin than Ara-C; however, the response of HEL cells to the two agents was much less pronounced, and ation, hybridization and washing were carried out as outlined previously. 10 Radioactive ETS-1 signal was quantified relative untreated HEL cells consistently exhibited a lower level (Ͻ1%) of background staining relative to that observed in K562 (3-to ␤-actin or glyceraldehyde-3-phosphate dehydrogenase (GPDH) using an AMBIS radioanalytical imaging system 7%).
Figure 2
The effect of hemin and Ara-C on ETS-1 RNA levels in HEL cells. HEL cells cultured in suspension were treated with Ara-C (a) or hemin (b). Cells were harvested at the indicated times. RNA was isolated, Northern blotted, and the filters were subsequently hybridized to probe specific for ETS-1 and ␤-actin. Radioactive signal was quantified using an Ambis radioanalytical imaging system. The graph shows levels of ETS-1-specific signals standardized to signals of the ␤-actin control.
significant decrease in the levels of ETS-1 mRNA was observed in HEL cells treated with Ara-C at the time points examined, and over the 5 day treatment period ETS-1 mRNA levels steadily increased to more than four times the basal level ( Figure 2 ). Changes in the ETS-1 levels appear to be a lineage-specific effect of hemin and Ara-C, since following hemin or Ara-C treatment of RAJI-B (B lymphoid) and KG-1 (myelomonocytic) cells we did not detect any change in the basal level of ETS-1, ETS-2 or FLI-1 transcripts (data not shown). Consistent with previous observations 31 ETS-1 RNA could not be detected in K562 cells by Northern blot analysis under similar conditions. ated following treatment with inducers of erythroid differentiation, we tested whether ETS-1 transcription contributes directly to hemin or Ara-C induced hemoglobinization of Ara-C and hemin differentially affect levels of ETS-1 mRNA present in HEL cells K562 or HEL cells by using antisense oligonucleotides to block ETS-1 expression following induction. The percentage of K562 cells staining positive for hemoglobin after a 38 h The expression of many different ETS genes has previously been demonstrated in a variety of human leukemic cell lines treatment with Ara-C or hemin was 8 and 28%, respectively, relative to 1-3% staining in the untreated control, but followincluding K562 and HEL. 31 We analyzed ETS gene expression in our K562 and HEL cell lines and found that, consistent with ing treatment with the 17-mer antisense oligonucleotide, AS 1, hemin-and Ara-C-induced hemoglobinization was previous reports, transcripts for ETS-1, ETS-2 and FLI-1 were present at very low or undetectable levels in K562 cells but inhibited two-to five-fold or four-to seven-fold, depending on the experiment (Figure 3a) . In HEL cells, AS 1 inhibited were readily detectable in HEL cells (data not shown). In cells treated with hemin or Ara-C, only the levels of ETS-1 mRNA hemin-and Ara-C-induced hemoglobinization 1.5-to twofold and two-to four-fold, respectively (Figure 3b ). Neither the were affected. In Figure 2a , despite the apparent decrease in ␤-actin mRNA expression relative to that of ETS-1, four inde-ETS-1 sense or nonspecific control oligonucleotides inhibited hemoglobinization in response to hemin or Ara-C. Furtherpendent experiments indicated that hemin treatment of HEL cells leads to increased ETS-1 mRNA expression relative to more, Western blot analysis of HEL cell extracts confirmed that Ara-C-treated cells incubated with AS-1 expressed that of ␤-actin, GPDH or the ETS family member FLI-1. Direct quantification of the radioactive signal revealed that ETS-1 decreased levels of the phosphorylated and dephosphorylated forms of the ETS-1 protein relative to Ara-C-treated cells incumRNA expression decreased within 4 h in HEL cells incubated with hemin, and that this initial decrease was followed by a bated with no oligonucleotide or ETS-1 sense oligonucleotides ( Figure 4 ). These data, in combination with the finding that steady increase in ETS-1 mRNA levels, which by 5 days treatment were twice the basal level of expression (Figure 2) . No ETS-1 expression is upregulated in response to hemin or Ara-C suggest that ETS-1 transcription contributes to the mechanisms underlying hemin-and Ara-C-mediated responses.
K562 and HEL cells expressing elevated levels of ETS-1 protein exhibit a decrease in cellular proliferation and a concomitant increase in erythroid phenotype
To test whether increased levels of ETS-1 might contribute positively to the induction of erythroid-specific markers, we generated a series of drug-selectable retroviral vectors expressing ETS-1 and ETS-2 in either their sense or antisense orientations (see Materials and methods). Helper-free viral stocks generated in the amphotropic murine packaging cell line PA317 were used to infect K562 and HEL cells and infected cells were cultured in media containing G418 (800 g/ml) for 1-2 weeks to select infected drug-resistant cell pools for subsequent analysis. Northern blot analysis confirmed that the levels of mRNA specific for ETS-1 and ETS-2 in the K562 and HEL-infected cell lines were notably higher than endogenous levels ( Figure 5a ). In a typical experiment the virally transduced ETS-1 mRNA was observed following a 30 min exposure to film, whereas endogenous ETS-1 mRNA could be seen in HEL cells after a 24 h exposure to film, and could not be seen in K562 cells even after a 72 h exposure to film. The virally transduced ETS-1 mRNA correlated with an increase in the amount of ETS-1 protein as detected in Western blots (Figure 5b ). Interestingly, although the levels of virally transduced ETS-1 mRNA were notably higher than endogenous, only slight increases in ETS-1 protein expression were observed in the LE1-infected HEL cell population (Figure 5b ). This may indicate post-transcriptional mechanisms in the regulation of the levels of ETS-1 protein expression or a selection against higher levels of ETS-1 in proliferating cells. LE1-infected K562 and HEL cells continued to express elevated levels of ETS-1 mRNA for up to 8 weeks in culture (longest time point examined) with no effect on cell viability. How- despite high levels of ETS-2 mRNA, no effects or hemoglobinization of cells or proliferation were observed (data not shown).
We also observed that following centrifugation pellets of LE1-infected K562 and HEL cells were red, indicating an increase in hemoglobin expression. The increase was confirmed by comparison of benzidine-stained LE1-infected cell populations relative to uninfected or virus-infected control cells (Table 1) . Infection with LE1 was essentially as effective as either compound at inducing K562 cells, while it was as effective as Ara-C and half as effective as hemin in inducing HEL cells. Consistent with increased hemoglobin levels, the level of expression of several lineage-specific surface markers indicated that ETS-1-infected K562 and HEL cells exhibited a more erythroid phenotype. ETS-1-infected K562 and HEL cells (Table 2) , and transferrin receptor (CD71) expression also was lowing exposure to Ara-C, ETS-1 protein levels in extracts from control increased by two-fold in the LE1-infected HEL cell population. Interestingly, in addition to the erythroid-specific markers, we determined by Western blot analysis as described in Materials and methods.
noted an increase in the megakaryocytic markers glycoprotein Expression of ETS-1 in infected K562 and HEL cell popucultured as described in Materials and methods. At the indicated time lations. The levels of ETS-1 RNA present in K562 and HEL cells points, cells were quantified using a hemocytometer. Cell number vs infected with control virus (LRNL), LE1 (E1S) or LE1AS (E1AS) were time was plotted as an indication of proliferative rate. determined by Northern blot analysis (a). Hybridization to actin was used to control for differences in sample loading. Table 2 ). The pattern of surface marker expression was similar hemin or Ara-C, respectively. A similar effect was observed in to those observed on the surface of K562 cells treated with HEL cells (Figure 7b) , with the percentage of HEL cells staining Ara-C, which in our hands also induced small increases in positive for hemoglobin rising from ϽϽ1% in the controls to megakaryocytic marker expression in HEL cells. ETS-1 2-6% in the LE1-infected population. Thus, the maximal level expression, however, had no effects on these markers in HEL of benzidine staining was higher in LE1 infected cells although cells, and no changes relative to the controls in the levels of the relative increase was similar in both cases. However, CD14 (monocytic) were detected in either K562 or HEL cells while very little response was seen in the control populations expressing virally transduced ETS-1 protein (Table 2) .
within the first 24 h of treatment, a 24 h treatment of LE1-infected cells with hemin or Ara-C resulted in a respective 10 K562 and HEL cell lines expressing elevated levels of and 20% of the infected cells staining positively for hemoglo-
ETS-1 protein demonstrate increased sensitivity to bin. Our data show that cells expressing increased levels of hemin and Ara-C ETS-1 exhibited both a more rapid increase in, and higher percentage of, benzidine staining than their uninfected controls, Since LE1-infected HEL and K562 cells had a more erythroid phenotype relative to controls, it was of interest to determine and this differential effect was seen over the entire 72 h induc- Cells were infected with stocks of control (LRNL) or ETS-1-expressing (E1S) virus, selected for 14-21 days in media containing G418 (400 g/ml), and then stained for Hb.
Table 2
Relative mean fluoresence intensity of K562 and HEL cells stained for cell surface markers following Ara-C treatment or infection by control or ETS-1-expressing retroviruses
Uninfected K562 and HEL cells treated with Ara-C, and control (LRNL) and ETS-1-expressing (LE1) virus-infected cells were grown and analyzed by flow cytometry for the expression of surface markers as described in Materials and methods. Values are expressed as ratios of mean fluorescence (log) relative to that detected on uninfected controls and are reported as the average ± s.d. of two independent experiments. NT, not tested.
tion period we tested. The number of LE1-infected HEL cells staining positive for hemoglobin after 48 h treatment with hemin or Ara-C reached 60% in response to hemin and 25% in response to Ara-C, as compared to 8 and 3% in the uninfected and vector-infected controls (Figure 7b ). We noted that after a long period of culture the basal percentage of benzidine-positive cells and the inducibility of erythroid markers by hemin and Ara-C decreased, possibly reflecting a growth advantage of a less differentiable cell clone. ets fusion of the E26 virus causes predominantly an erythro-leukemia and transforms pluripotent hematopoietic progenitor to propose that erythroid differentiation pathways converge at the level of ETS-1 expression. The results of the antisense inhicells, 7, 8 cellular ETS-1 is expressed in immature hematopoietic cells of the erythroid lineage as well as in hematopoietic bition experiments argue that ETS-1 is essential for this response, and are also interesting considering the current tissues in the developing mouse, 30, 31, 58, 59 and it has recently been reported that the MafB gene product binds to the DNA axiom that Ara-C induces an erythroid phenotype by inhibiting DNA replication, while hemin utilizes mechanisms binding domain of ETS-1 and inhibits erythroid differentiation of chicken hematopoietic progenitors. 60 It was suggested that which are different from those of Ara-C. [63] [64] [65] [66] [67] Our finding that ETS-1 expression contributes to the hemoglobinization in MafB is an interaction partner and repressor of ETS-1, and that is elevated expression inhibits erythroid differentiation. Our response to hemin or Ara-C treatment suggests an integral role for ETS-1 expression in erythroid differentiation in both findings are consistent with those observations and further support the hypothesis that the ETS-1 gene has a role in mechanisms.
Discussion
Sieweke et al 60 have recently identified a novel protein, erythroid differentiation.
We observed that ETS-1 but not ETS-2 or FLI-1 gene MafB, which binds to ETS-1 and is thought to down-regulate the expression of genes such as porphobilinogen deaminase expression was elevated in HEL cells treated with either Ara-C or hemin, both of which induce an erythroid phenotype.
(PBGD) and transferrin receptor and inhibit subsequent erythroid differentiation. The presence of such an inhibitory Furthermore, ETS-1 antisense oligonucleotides inhibited hemoglobinization of K562 and HEL cells in response to treatprotein in K562 and HEL cells would explain how a relatively small increase in the already high basal ETS-1 level in HEL ment with either drug. Consistent with these observations, infection with a retrovirus expressing ETS-1 induced the cells can still lead to progression to a more erythroid phenotype. Uninfected or control virus-infected K562 and HEL cells expression of erythroid-specific markers to levels comparable to those of Ara-C-treated cells. The LE1 retrovirus, like the constitutively express high levels of transferrin receptor, and although transferrin receptor is up-regulated in response to erythroid inducer Ara-C [52] [53] [54] [55] [56] [57] , also induced slight but reproducible increases in the expression of megakaryocytic markers in ETS-1 expression only in HEL cells, chemical or retroviralinduced induction of ETS-1 expression still induces increased K562 cells, albeit these increases were small relative to those following treatment with TPA, 61 a well-characterized inducer glycophorin A and hemoglobin expression in both cell lines. These data suggest that in addition to transferrin receptor, ETSof the megakaryocytic phenotype. Unlike Ara-C, however, LE1 did not increase the expression of megakaryocytic mark-1 affects the expression of other erythroid genes. We are currently examining the effects of exogenous ETS-1 expression on ers in HEL cells, and furthermore, the LE1-infected K562 and HEL cell populations were more sensitive to induction by a number of genes which have been suggested to be responsive to ETS-1 including the erythroid-specific PBGD, GATAhemin and Ara-C. These data suggest a specific contribution of ETS-1 to the development of an erythroid phenotype, and 1, Tal-1 and c-mpl. K562 and HEL cells expressing elevated levels of ETS-1 also this is supported by the finding that virus expressing ETS-2 failed to alter the behavior of either cell line.
show a reduced rate of proliferation. The treatment of erythroleukemic cell lines with drugs that block DNA replication and We had previously shown that infection of K562 cells with a virus expressing FLI-1, another member of the ETS gene faminhibit cellular proliferation results in a more mature erythroid phenotype, [68] [69] [70] and data from a number of laboratories sugily, induced dramatic changes in cell morphology as well as increases in the levels of megakaryocytic surface markers and gest that myeloid differentiation is tightly linked to inhibition of cellular proliferation or extension of the G1 phase of the Hb expression. 61 While the effects on the pattern of gene expression are similar, the magnitude of the effects are sigcell cycle. [70] [71] [72] [73] It is possible that in K562 and HEL cells virally transduced ETS-1 blocks or inhibits cell cycle progression, nificantly different, especially in the levels of expression of megakaryocytic markers, which are much higher in FLI-1-leading to a more erythroid phenotype. This possibility is especially interesting in light of recent data demonstrating a expressing K562 cells. 61 Our finding that the megakaryocytic GPIIb/IIIa complex is upregulated in K562 cells expressing direct physical interaction between ETS-1 and AP1 transcription factors, 74 and this is consistent with observations in this virally transduced ETS-1 is consistent with previous data demonstrating that this gene promoter is responsive to ETS-1. 62 laboratory and others that Ara-C treatment inhibits proliferation of K562 and HEL cells. 67, [75] [76] [77] The effect of ETS-1 on However, this effect is dependent on other factors in the cellular background, since ETS-1 did not appear to affect this gene proliferation is not essential for the induction of the erythroid phenotype since in our studies hemin treatment did not inhibit expression in HEL cells. The fact that ETS-1 and FLI-1 can induce expression of the same phenotypic markers is consist-HEL cell proliferation despite its ability to induce erythroid markers. Similarly, although the specific effects of hemin on ent with the highly related DNA binding specificity of ETS gene family members, all of which recognize the core GGA K562 cells appear to depend on the particular clone, 78, 79 it is most likely that ETS-1 contributes to erythroid differentiation A/T target sequence.
1,2 Our finding that ETS-1 is a consistent inducer of erythroid markers, while FLI-1 is a more potent as a direct effector of erythroid-specific gene expression rather than indirectly through cell cycle inhibition. Consistent with inducer of megakaryocytic markers, may indicate lineage specificity of these transcription factors. Alternatively, this hypothesis, ETS-1 has been shown to induce expression of transferrin receptor and transactivate myeloid-specific although we have observed effects of ETS-1 and FLI-1 on erythroid and megakaryocytic marker expression on these cell genes in vitro.
80,81
It should be noted that ETS-1 overexpression has been systems, it is possible that a related member(s) of the ETS gene family may be the true inducer(s) of the erythroid or megakarshown to induce increased proliferation and even transformation in some cell lines. 82 Differences between our studies and yocytic marker expression in vivo, or that ETS-1 and FLI-1 genes act indirectly to activate erythroid and megakaryocytic those from other laboratories with regard to effects of ETS-1 on proliferation may simply reflect the diversity of the cellular expression pathways.
Because elevated expression of ETS-1 correlates with backgrounds. Factors such as TGF␤ are known to have both proliferative and antiproliferative effects on different cell increased levels of erythroid-specific markers both in virusinfected and hemin-and Ara-C-treated cells, it is reasonable lines, 83 ,84 and it is not unreasonable that specific transcription increases ETS-1 levels in HEL cells with no effect on cellular 13 erythroid phenotype by ETS-1.
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